10x Genomics Blog 7. Nov. 2025 Barclays Maintains 10x Genomics (TXG) Overweight Recommendation - Nasdaq #Overweight Recommendation #Barclays Maintains
Illumina 1. Nov. 2025 Barclays Maintains Illumina (ILMN) Underweight Recommendation - Nasdaq #Maintains Illumina #Underweight Recommendation